Humana Inc. (NYSE:HUM) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday.
A number of other analysts have also commented on HUM. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $237.00 price target on the stock in a report on Tuesday, April 18th. Jefferies Group LLC lowered Humana from a “buy” rating to a “hold” rating and cut their price target for the company from $237.00 to $221.00 in a report on Friday, April 21st. Cowen and Company restated an “outperform” rating and issued a $230.00 price target on shares of Humana in a report on Tuesday, April 25th. Evercore ISI restated an “outperform” rating and issued a $240.00 price target on shares of Humana in a report on Tuesday, April 25th. Finally, Cantor Fitzgerald boosted their price target on Humana from $190.00 to $200.00 and gave the company a “neutral” rating in a report on Wednesday, April 26th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $243.65.
Humana (NYSE HUM) traded down 0.55% on Thursday, reaching $253.57. The company had a trading volume of 119,076 shares. The stock has a market capitalization of $36.65 billion, a price-to-earnings ratio of 20.86 and a beta of 0.91. Humana has a 12 month low of $163.50 and a 12 month high of $255.27. The firm has a 50 day moving average price of $238.81 and a 200-day moving average price of $222.35.
Humana (NYSE:HUM) last posted its earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.08 by $0.41. The firm had revenue of $13.53 billion for the quarter, compared to analyst estimates of $13.61 billion. Humana had a return on equity of 15.85% and a net margin of 3.37%. During the same period in the previous year, the company posted $2.30 earnings per share. Analysts forecast that Humana will post $11.55 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This article was first published by Ticker Report and is owned by of Ticker Report. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://www.tickerreport.com/banking-finance/2798202/humana-inc-nysehum-upgraded-at-bidaskclub.html.
In related news, SVP Brian P. Leclaire sold 4,971 shares of the business’s stock in a transaction that occurred on Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total value of $1,193,040.00. Following the completion of the sale, the senior vice president now directly owns 14,258 shares in the company, valued at $3,421,920. The sale was disclosed in a filing with the SEC, which is available at this link. Also, VP Heidi S. Margulis sold 1,500 shares of the business’s stock in a transaction that occurred on Friday, May 26th. The shares were sold at an average price of $231.96, for a total value of $347,940.00. Following the completion of the sale, the vice president now owns 8,150 shares of the company’s stock, valued at $1,890,474. The disclosure for this sale can be found here. Insiders own 0.80% of the company’s stock.
Large investors have recently modified their holdings of the stock. Independent Portfolio Consultants Inc. boosted its stake in shares of Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock valued at $125,000 after buying an additional 94 shares during the period. Fiduciary Trust Co. bought a new stake in shares of Humana during the second quarter valued at about $135,000. Guardian Life Insurance Co. of America boosted its stake in shares of Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after buying an additional 4 shares during the period. Point72 Asia Hong Kong Ltd bought a new stake in shares of Humana during the first quarter valued at about $128,000. Finally, Westbourne Investment Advisors Inc. bought a new stake in shares of Humana during the second quarter valued at about $205,000. Institutional investors and hedge funds own 99.66% of the company’s stock.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.